Venture Capital Firm Inflection Point Launches $110 Million Angel Fund, 'IPV International', in GIFT City; Prioritizing high-growth sectors while remaining flexible across industries.
New $110 Million Global Angel Fund, IPV International, Launches in GIFT City
Inflection Point Ventures (IPV) has unveiled its new international fund, IPV International, with a total corpus of USD 110 million. The fund is registered as a Category I Angel Fund under the International Financial Services Centres Authority (IFSCA) at GIFT City [1][2][3].
IPV International focuses on early-stage to pre-Series A investments globally, including both Indian and international startups. Investment ticket sizes range from USD 100,000 to USD1 million [1][2][3]. The fund aims to capitalize on the evolving global startup landscape by participating in cross-border deals, leveraging GIFT City's regulatory framework to attract a diverse investor base [1][2][4].
Key features and focus of IPV International include:
- Cross-border investment platform: The fund is open for participation from non-resident Indians (NRIs), overseas citizens of India (OCIs), and foreign nationals, aiming to provide international exposure and diversification [1][3][4].
- Sector-agnostic with strategic focus: While IPV International invests across various sectors, it maintains a strategic focus on high-growth sectors. Its first investment was in Cellivate Technologies, a Singapore-based deeptech biotech startup innovating an ethical alternative to fetal bovine serum used in pharmaceuticals and biotech research [1][2][3][4].
- Fully licensed and operational under GIFT City’s framework: IPV International holds a Fund Registration Certificate and Fund Management Entity license from IFSCA, allowing it to operate seamlessly within GIFT City’s global financial ecosystem [1][4].
- Leveraging IPV’s experience and network: The fund expands IPV’s presence beyond the Indian startup ecosystem, tapping into global startup capital [1][3][4].
IPV International is now operational and aims to broaden cross-border investment access for both domestic and international investors. The fund intends to use GIFT City's platform to tap into cross-border opportunities and engage more directly with international startup ecosystems [1][2].
Cellivate Technologies, the first investment of IPV International, is a testament to the fund's focus on high-growth areas. Based in Singapore, the deeptech startup is developing a scalable, ethical alternative to fetal bovine serum for use in biotech and pharmaceutical research [1][2][3].
GIFT City's regulatory framework aims to be more flexible and innovation-oriented compared to domestic structures, making it an attractive location for international funds like IPV International [1][4]. Participation in IPV International does not require Indian tax filings, provided their only India-sourced income is from GIFT City [1].
In summary, IPV International is designed as a global, sector-agnostic angel fund focusing on early-stage to pre-Series A startups. It leverages GIFT City's international regulatory framework to facilitate cross-border investments and a broad, diverse portfolio with ticket sizes from $100K to $1M. Its launch marks IPV's strategic expansion into the global startup investment arena [1][2][3][4].
[1] - [Source 1] [2] - [Source 2] [3] - [Source 3] [4] - [Source 4] (if applicable)
- The management of IPV International, a new $110 million global angel fund, aims to capitalize on the evolving global startup landscape by making investments in high-growth sectors, leveraging GIFT City's regulatory framework to attract a diverse investor base.
- IPV International, a sector-agnostic fund registered in GIFT City, intends to use finance from its corpus to provide growth capital for both Indian and international startups, with investment ticket sizes ranging from $100,000 to $1 million.
- With GIFT City's platform, IPV International, an international fund focused on early-stage to pre-Series A investments, aims to broaden cross-border investment access for both domestic and international investors, tapping into global technology startups and ecosystems.
